Bellerophon Announces Closing of $15.3 Million Registered Direct Offering of Common Stock
WARREN, N.J., April 01, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics […]